TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1693762

Group type: EXPERIMENTAL
Intervention: 5 mg and 10 mg of heroin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1 mg and 2 mg of hydromorphone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repeated doses of the same drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repeated doses of the alternate drug
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both drugs (heroin and hydromorphone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Covariate analysis
Number of subjects: 0
Study: 489201

Group type: EXPERIMENTAL
Intervention: Metoprolol 40 mg orally
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31977110

Group type: EXPERIMENTAL
Intervention: Mothers of preterm infants
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Fathers of preterm infants
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Very preterm infants' mothers
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Parents of twins
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Parents with lower perceived general health
Number of subjects: 547
Study: 30359681

Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneously every 4 weeks plus standard of care
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 347
Study: 28317287

Group type: EXPERIMENTAL
Intervention: Active pharyngeal electrical stimulation (PES) at 5 Hz, 75% of maximal tolerated intensity, for 10 minutes once a day for three consecutive days.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham pharyngeal electrical stimulation (PES)
Number of subjects: 38
Study: 24739801

Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 23498594

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (OCSs) treatment during acute LRTIs, n = 70
Number of subjects: 493

Group type: COMPARATOR
Intervention: No treatment with OCSs during acute LRTIs, n = 42
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (OCSs) treatment during severe LRTIs, n = 133 (from the second cohort)
Number of subjects: 493
Study: 21221987

Group type: EXPERIMENTAL
Intervention: Static hand grip test (HGT) at 30% of maximal voluntary contraction
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Trapezius muscle blood flow (MBF) during HGT
Number of subjects: 45
Study: 19961455

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Rhodamine B (RB)
Number of subjects: 172
Study: 17762748

Group type: EXPERIMENTAL
Intervention: fMRI hyperactivation during the first week of recovery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: fMRI results
Number of subjects: 0
Study: 15293971

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg as a single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mebendazole (Janssen, 100 mg twice a day for three days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mebendazole (Unibios, 100 mg twice a day for three days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mebendazole (East African Pharmaceuticals, 100 mg twice a day for three days)
Number of subjects: 0
Study: 11444712

Group type: EXPERIMENTAL
Intervention: EMLA cream (lidocaine/prilocaine) applied 45 minutes before intravenous cannulation
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo applied 45 minutes before intravenous cannulation
Number of subjects: 57
Study: 9655746

Group type: EXPERIMENTAL
Intervention: Histamine challenge
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) challenge
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Adenosine 5'-monophosphate (AMP) challenge
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isotonic saline (IS) challenge
Number of subjects: 20
Study: 7712340

Group type: EXPERIMENTAL
Intervention: Raw carrots
Number of subjects: 10

Group type: COMPARATOR
Intervention: Microwaved carrots
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Processed carrots (blanched and frozen)
Number of subjects: 10
Study: 2750692

Group type: EXPERIMENTAL
Intervention: Air-expanded whole-wheat protein product (SNW) as a meal substitute for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard low-calorie diet (LCD)
Number of subjects: 0
Study: 335516

Group type: EXPERIMENTAL
Intervention: Cranial irradiation plus intrathecal therapy during early remission
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Involved field irradiation during induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate for prophylaxis of CNS disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irradiation to areas of bulk disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternate regimens to the Memorial Hospital LSA2-L2 regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose methotrexate in combination drug treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First or second look laparotomy for surgical bulk reduction
Number of subjects: 0
Study: 31398231

Group type: EXPERIMENTAL
Intervention: Care management intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27709313

Group type: EXPERIMENTAL
Intervention: DA-3031 (6 mg on day 2 of each chemotherapy cycle)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Filgrastim (100 μg/m2/day for up to 10 days)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Filgrastim
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: DA-3031
Number of subjects: 74
Study: 25133860

Group type: EXPERIMENTAL
Intervention: Walking workstation
Number of subjects: 10
Study: 23616163

Group type: EXPERIMENTAL
Intervention: Low-dose propranolol (20 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High-dose propranolol (80 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 11
Study: 21672315

Group type: EXPERIMENTAL
Intervention: tamsulosin 0.2 mg orally once daily for 4 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: silodosin 4 mg orally twice daily for 4 weeks
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: tamsulosin
Number of subjects: 102

Group type: COMPARATOR
Intervention: silodosin
Number of subjects: 102
Study: 19114862

Group type: EXPERIMENTAL
Intervention: tipranavir/ritonavir (TPV/r) 500/200 mg twice daily (b.i.d.)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control group (men)
Number of subjects: 203
Study: 16917168

Group type: EXPERIMENTAL
Intervention: Tactor trials (balance prosthesis activated)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control trials (balance prosthesis not activated)
Number of subjects: 0
Study: 12590854

Group type: EXPERIMENTAL
Intervention: 4% boric acid solution in alcohol and frequent suction cleaning of the ear canal
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: tioconazole ointment
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (Candida albicans isolate)
Number of subjects: 87
Study: 10487457

Group type: EXPERIMENTAL
Intervention: BMV foam 0.12%
Number of subjects: 72

Group type: COMPARATOR
Intervention: BMV lotion
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 8707075

Group type: EXPERIMENTAL
Intervention: Psychological stress (Stroop test)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physical stress (cold pressor test)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no stress)
Number of subjects: 60
Study: 1923295

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 7202249

Group type: EXPERIMENTAL
Intervention: Trimethoprim (TMP), 300 mg once a day for seven days (group 1)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Trimethoprim (TMP), 200 mg once a day for 10 days (group 2)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin, 100 mg four times a day for 10 days (group 3)
Number of subjects: 322
Study: 3936374

Group type: EXPERIMENTAL
Intervention: alfentanil
Number of subjects: 51

Group type: COMPARATOR
Intervention: isoflurane
Number of subjects: 51
Study: 30216138

Group type: EXPERIMENTAL
Intervention: Organized recess
Number of subjects: 281

Group type: COMPARATOR
Intervention: Supervised recess
Number of subjects: 281
Study: 26159208

Group type: EXPERIMENTAL
Intervention: 35% HP + LED/laser
Number of subjects: 22

Group type: COMPARATOR
Intervention: 35% HP
Number of subjects: 22
Study: 25440792

Group type: EXPERIMENTAL
Intervention: STENTYS self-apposing nitinol bare-metal stent
Number of subjects: 212

Group type: COMPARATOR
Intervention: Balloon-expandable bare-metal MULTI-LINK stent
Number of subjects: 212
Study: 22789795

Group type: EXPERIMENTAL
Intervention: Spiritual ceremony
Number of subjects: 10
Study: 20357041

Group type: EXPERIMENTAL
Intervention: Approximately 4 hours of sleep (from 0200 to 0600)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Approximately 8 hours of sleep (from midnight to 0800)
Number of subjects: 12
Study: 18773686

Group type: EXPERIMENTAL
Intervention: Conservative drug therapy + Su Jok therapy with laser ray at acupuncture points
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conservative drug therapy only
Number of subjects: 100
Study: 16216060

Group type: EXPERIMENTAL
Intervention: Azosemide (30 mg/d for cardiac/renal edema; 60 mg/d for hepatogenic edema)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Furosemide (20 mg/d for cardiac/renal edema; 40 mg/d for hepatogenic edema)
Number of subjects: 223
Study: 14693730

Group type: EXPERIMENTAL
Intervention: Higher concentrations of testosterone (T)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Free testosterone (free T)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Percentage of free testosterone
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Total testosterone:sex hormone binding globulin ratio
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Androstenedione
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Dehydroepiandrosterone sulfate
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 3 alpha‐androstanediol glucuronide
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Total estradiol (E2)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Free estradiol (free E2)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Percentage of free estradiol
Number of subjects: 600
Study: 10507606

Group type: EXPERIMENTAL
Intervention: Fenoldopam 0.03 µg/kg/min
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fenoldopam 0.1 µg/kg/min
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fenoldopam 0.3 µg/kg/min
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fenoldopam
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 8619353

Group type: EXPERIMENTAL
Intervention: iobitridol
Number of subjects: 276

Group type: COMPARATOR
Intervention: iohexol
Number of subjects: 276
Study: 1934205

Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Patient-controlled intravenous morphine
Number of subjects: 30
Study: 7138727

Group type: EXPERIMENTAL
Intervention: Oral diazepam alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral diazepam with atropine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral diazepam with hyoscine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (diazepam alone)
Number of subjects: 8
Study: 31852287

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN) plus 25 µg sublingual misoprostol
Number of subjects: 122

Group type: COMPARATOR
Intervention: Misoprostol plus placebo
Number of subjects: 122
Study: 30798267

Group type: COMPARATOR
Intervention: School-level rigid boundaries
Number of subjects: 0

Group type: COMPARATOR
Intervention: Student belonging
Number of subjects: 0

Group type: COMPARATOR
Intervention: Student commitment
Number of subjects: 0
Study: 29017658

Group type: EXPERIMENTAL
Intervention: armed stabilization device
Number of subjects: 167

Group type: COMPARATOR
Intervention: unarmed stabilization device
Number of subjects: 167
Study: 27684379

Group type: EXPERIMENTAL
Intervention: Immediate treatment for patients with two consecutive viraemia episodes below 3000 genomes/ml
Number of subjects: 59

Group type: COMPARATOR
Intervention: Monitoring for patients with two consecutive viraemia episodes below 3000 genomes/ml
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Stopping treatment when viraemia is less than 200 genomes/ml
Number of subjects: 59

Group type: COMPARATOR
Intervention: Stopping treatment when viraemia is less than 3000 genomes/ml
Number of subjects: 59
Study: 24402855

Group type: EXPERIMENTAL
Intervention: Educational intervention (6 classes)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 22236770

Group type: EXPERIMENTAL
Intervention: Self-adhesive resin cement (RelyX Unicem, RX, 3M ESPE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Etch-and-rinse multistep adhesive (Syntac Classic, Ivoclar‐Vivadent) and Variolink II low (SV, Ivoclar‐Vivadent)
Number of subjects: 30
Study: 18753005

Group type: EXPERIMENTAL
Intervention: Discontinuation of tricyclic antidepressants (TCAs)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Discontinuation of selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (previously untreated patients)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Overall comparison of TCAs vs SSRIs
Number of subjects: 57
Study: 17235721

Group type: EXPERIMENTAL
Intervention: Laparoscopic transabdominal (TAPP)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Laparoscopic totally extra peritoneal (TEP)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Open inguinal hernia repair with polypropylene mesh (Lichtenstein type)
Number of subjects: 66

Group type: COMPARATOR
Intervention: All groups (TAPP, TEP, Lichtenstein)
Number of subjects: 66
Study: 15098798

Group type: EXPERIMENTAL
Intervention: zidovudine plus lamivudine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ritonavir plus zidovudine and lamivudine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ritonavir plus stavudine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ritonavir plus stavudine and nevirapine
Number of subjects: 21
Study: 14597359

Group type: EXPERIMENTAL
Intervention: External beam radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 10625023

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention group (education, peer‐comparison feedback, academic detailing)
Number of subjects: 1810

Group type: COMPARATOR
Intervention: Education only group
Number of subjects: 1810
Study: 7856779

Group type: EXPERIMENTAL
Intervention: 5-year education program including Quit and Win contests, classes, self-help materials, telephone support, and home correspondence programs.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison communities (control group)
Number of subjects: 0
Study: 1755638

Group type: EXPERIMENTAL
Intervention: Intermittent treatment for covert bacteriuria for the first four years
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 58
Study: 6352366

Group type: EXPERIMENTAL
Intervention: pirprofen 400 mg b.i.d.
Number of subjects: 39

Group type: COMPARATOR
Intervention: indomethacin 50 mg b.i.d.
Number of subjects: 39
Study: 29729427

Group type: EXPERIMENTAL
Intervention: Prednisolone (PRED) 7.5 mg once daily (n=12)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Prednisolone (PRED) 30 mg once daily (n=12)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (n=8)
Number of subjects: 32
Study: 27345175

Group type: EXPERIMENTAL
Intervention: Live attenuated hepatitis A vaccine (HA-L)
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A vaccine (HA-I)
Number of subjects: 6000
Study: 24160850

Group type: EXPERIMENTAL
Intervention: Arsenic trioxide (ATO)
Number of subjects: 245
Study: 22099722

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Supportive Therapy (ST)
Number of subjects: 76
Study: 20442102

Group type: EXPERIMENTAL
Intervention: 1064-nm/1320-nm laser-assisted lipolysis (iLAL)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Tumescence treatment
Number of subjects: 3

Group type: COMPARATOR
Intervention: Cannulation treatment
Number of subjects: 3

Group type: COMPARATOR
Intervention: Volume reduction after liposuction
Number of subjects: 3

Group type: COMPARATOR
Intervention: Deep lasing plus liposuction
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Shallow lasing, liposuction, and deep lasing
Number of subjects: 3
Study: 17655677

Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) pacing
Number of subjects: 1636

Group type: COMPARATOR
Intervention: Right ventricular (RV) pacing
Number of subjects: 1636
Study: 16055646

Group type: EXPERIMENTAL
Intervention: Perceived opportunity in life domains
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regret ranking studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laboratory evidence from Study Set 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study Set 3
Number of subjects: 0
Study: 12168923

Group type: EXPERIMENTAL
Intervention: Octreotide 600-800 microg/day and chlorpromazine (15-25 mg/day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Hyoscine butylbromide 60-80mg/day and chlorpromazine (15-25 mg/day)
Number of subjects: 68
Study: 9793253

Group type: EXPERIMENTAL
Intervention: Fibrinogen levels
Number of subjects: 2111

Group type: EXPERIMENTAL
Intervention: White blood cell (WBC) count and serum cholesterol levels
Number of subjects: 2111

Group type: EXPERIMENTAL
Intervention: Regional distribution of fibrinogen levels
Number of subjects: 2111
Study: 8583349

Group type: EXPERIMENTAL
Intervention: Pressurized metered‐dose aerosol inhaler (125 micrograms per dose)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Novel mechanical pump spray device (500 micrograms per dose)
Number of subjects: 17
Study: 2714067

Group type: EXPERIMENTAL
Intervention: Cefotaxime (CTX) (2 Gm Q8H)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Cefoxitin (2 Gm Q6H)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Clindamycin (900 mg Q8H) and Gentamicin (3-5 mg/kg/day in divided doses Q8H)
Number of subjects: 129
Study: 788731

Group type: EXPERIMENTAL
Intervention: Indomethacin (200 mg daily)
Number of subjects: 6
Study: 31021713

Group type: EXPERIMENTAL
Intervention: Estrogen hormone therapy (HT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Estrogen alone (E-alone)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Estrogen with progestin (E + P)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Delayed testing
Number of subjects: 100
Study: 28802814

Group type: EXPERIMENTAL
Intervention: 8-week regimen of grazoprevir (100 mg/day), ruzasvir (60 mg/day), and uprifosbuvir (450 mg/day) with and without ribavirin
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: 12-week regimen of grazoprevir, ruzasvir, and uprifosbuvir with and without ribavirin
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: 12-week regimen of grazoprevir, ruzasvir, and uprifosbuvir with and without ribavirin among participants with cirrhosis infected with genotype 3
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: 16-week regimen of grazoprevir, ruzasvir, and uprifosbuvir with and without ribavirin
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 676
Study: 26381609

Group type: EXPERIMENTAL
Intervention: Healthy Habits telephone-based parent intervention
Number of subjects: 394
Study: 23679871

Group type: EXPERIMENTAL
Intervention: Computerised experimental training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 0
Study: 22152216

Group type: EXPERIMENTAL
Intervention: High-protein meal
Number of subjects: 38

Group type: COMPARATOR
Intervention: High-carbohydrate meal
Number of subjects: 38
Study: 19427180

Group type: EXPERIMENTAL
Intervention: Danhong Injection (DHI) administered intravenously
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine medication (control group)
Number of subjects: 80
Study: 16864724

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 988

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 988
Study: 12934420

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (2 mg/kg) administered 1 min before intubation
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (2 mg/kg) administered 3 min before intubation
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (2 mg/kg) administered 5 min before intubation
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (2 mg/kg) administered 10 min before intubation
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (no lidocaine)
Number of subjects: 135
Study: 11128559

Group type: EXPERIMENTAL
Intervention: Amoxycillin 45 mg/kg/day b.d.
Number of subjects: 517

Group type: COMPARATOR
Intervention: Amoxycillin 40 mg/kg/day t.d.s.
Number of subjects: 517
Study: 9129069

Group type: EXPERIMENTAL
Intervention: Ganciclovir 8 mg/kg/day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ganciclovir 12 mg/kg/day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ganciclovir (compassionate use)
Number of subjects: 42
Study: 7949548

Group type: EXPERIMENTAL
Intervention: Prednisone withdrawal (Group 1)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Serum creatinine < 1.7 mg/dl at the time of steroid withdrawal
Number of subjects: 28
Study: 3668883

Group type: EXPERIMENTAL
Intervention: Multimodal stress management training
Number of subjects: 0

Group type: COMPARATOR
Intervention: GSR biofeedback training (minimally effective treatment control)
Number of subjects: 0
Study: 31840339

Group type: EXPERIMENTAL
Intervention: FITNET-NHS treatment
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Linguistic features analysis
Number of subjects: 16